ARTICLE | Company News
Kemin, Meiji Seika Kaisha deal
June 15, 2009 7:00 AM UTC
Kemin's Amalyte Pharmaceuticals LLC subsidiary received an exclusive license to develop and commercialize ME3301/ AM3301 and its follow-on compounds outside Japan and several Asian countries, where M...